AbCellera vs ImCheck Therapeutics
AbCellera vs ImCheck Therapeutics, compared side by side on 15 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: AbCellera is on 41/100 and ImCheck Therapeutics on 60/100.
Where each one leads
AbCellera
- agent readiness: 38/100 against 34/100
- domain rating: 56/100 against 37/100
ImCheck Therapeutics
- our overall score: 60/100 against 41/100
- funding raised: $164M against $10.0M
At a glance
| Measure | AbCellera | ImCheck Therapeutics |
|---|---|---|
| What it is | AI-powered platform for antibody discovery and development to create new medicines. | ImCheck Therapeutics is a clinical-stage immuno-oncology company developing novel antibody therapies. |
| Category | Biotech, Drug Discovery, Genomics, AI Drug Discovery | Biotech, MedTech, HealthTech, Drug Discovery |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Biotech |
| Founded | 2012 | 2015 |
| Headquarters | Vancouver, Canada | Marseille, France |
| Status | Active | Active |
Size, funding and growth
| Measure | AbCellera | ImCheck Therapeutics |
|---|---|---|
| Employees | Not published | 47 |
| Total funding | $10.0M | $164M |
| Latest round | Public Offering | Not published |
| LinkedIn followers | Not published | 11,647 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | AbCellera | ImCheck Therapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 41/100 | 60/100 |
| Traction | 35/100 | 57/100 |
| Team | Not published | 70/100 |
| Community | Not published | 15/100 |
| Search visibility | 4/100 | 22/100 |
| Quality | 58/100 | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (38/100) | F (34/100) |
| Domain ratingLink authority, 0-100 | 56/100 | 37/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | AbCellera | ImCheck Therapeutics |
|---|---|---|
| Hosting | Not detected | Self Managed |
| CDN | Cloudflare | Not detected |
| CMS | Webflow | Not detected |
| Frameworks | Not detected | Jquery, Tailwind CSS, Bootstrap |
| Analytics | Google Tag Manager | Google Analytics 4 |
AbCellera vs ImCheck Therapeutics: common questions
Which is better, AbCellera or ImCheck Therapeutics?
On our 0-100 score ImCheck Therapeutics rates higher (60/100 against 41/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 15 data points above: read the rows that match what you are buying for.
How do AbCellera and ImCheck Therapeutics compare on the numbers?
AbCellera leads on agent readiness (38/100 against 34/100), domain rating (56/100 against 37/100). ImCheck Therapeutics leads on our overall score (60/100 against 41/100), funding raised ($164M against $10.0M).
Read the full AbCellera review and pricing or the ImCheck Therapeutics review and pricing. You can also browse other AbCellera alternatives we track.